EveliQure focuses on diarrhea, the most common illness in the world today with over 2 billion cases annually.

The company provides a unique, breakthrough solution based on its state-of-the-art proprietary development platform.

They are developing a vaccine to reduce the high disease burden of travelers and to save young children living in resource-poor countries.